𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and safety of topiramate in refractory epilepsy: a long-term prospective trial

✍ Scribed by A. Tartara; I. Sartori; R. Manni; C. A. Galimberti; M. Di Fazio; E. Perucca

Publisher
Springer Milan
Year
1996
Tongue
English
Weight
524 KB
Volume
17
Category
Article
ISSN
1590-1874

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term plasma exchange for severe ref
Long-term plasma exchange for severe refractory hypertriglyceridemia: A decade of experience demonstrates safety and efficacy
✍ Michal Schaap-Fogler; Daniel Schurr; Tova Schaap; Eran Leitersdorf; Deborah Rund 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Hypertriglyceridemia (hyperTG) is a common form of dyslipidemia and is frequently associated with premature coronary disease, and when severe, recurrent events of pancreatitis may occur. The management of hyperTG is generally medical (life style modification, medications). Plasma exchange (PE) has b

Determining the efficacy and cost-effect
Determining the efficacy and cost-effectiveness of the activalve: Results of a long-term prospective trial
✍ Donna J. Graville; Andrew D. Palmer; Peter E. Andersen; James I. Cohen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 267 KB

## Abstract ## Objectives/Hypothesis: To investigate 1) whether the Provox ActiValve results in increased device‐life in individuals with below average device‐life, 2) whether it is cost‐effective, and 3) whether it has any impact on voice‐related quality of life. ## Study Design: Prospective st

Long-term efficacy and safety of pramipe
Long-term efficacy and safety of pramipexole in advanced Parkinson's disease: Results from a European multicenter trial
✍ J. Carsten Möller; Wolfgang H. Oertel; Jürgen Köster; Gianni Pezzoli; Leandro Pr 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

## Abstract A double‐blind, placebo‐controlled study with a subsequent open‐label phase was conducted in 354 patients with Parkinson's disease (PD) and motor fluctuations under individually adjusted therapy with levodopa. During the double‐blind phase 174 patients received pramipexole and 180 place

Long-term safety and efficacy of long-ac
Long-term safety and efficacy of long-acting risperidone in elderly psychotic patients
✍ Werner Kissling; Per Glue; Rossella Medori; Steve Simpson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

## Abstract This subgroup analysis of the 6‐month, open‐label Switch to Risperidone Microspheres (StoRMi) trial evaluated long‐term safety and efficacy of a direct conversion to risperidone long‐acting injectable (RLAI) in 52 elderly patients (≥65 years) with psychosis stabilized on oral or depot a